Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis.


Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2024
Historique:
received: 17 04 2024
accepted: 19 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

Although chemoradiotherapy is an effective treatment for esophageal cancer, its feasibility in esophageal cancer with cirrhosis remains largely unclear. We retrospectively studied 11 patients with superficial esophageal cancer with liver cirrhosis (Child-Pugh score ≤8) who underwent radical chemoradiotherapy from four centers, and the overall survival rate, local control rate and adverse events at 1 and 3 years were explored. The median age of the included patients was 67 years (Inter-Quartile Range 60-75 years). Complete response was observed in most patients ( Radical chemoradiotherapy is a potential treatment option for patients with superficial esophageal cancer complicated with cirrhosis. However, it can increase the risk of bleeding, which warrants prompt recognition and intervention.

Sections du résumé

Background UNASSIGNED
Although chemoradiotherapy is an effective treatment for esophageal cancer, its feasibility in esophageal cancer with cirrhosis remains largely unclear.
Methods UNASSIGNED
We retrospectively studied 11 patients with superficial esophageal cancer with liver cirrhosis (Child-Pugh score ≤8) who underwent radical chemoradiotherapy from four centers, and the overall survival rate, local control rate and adverse events at 1 and 3 years were explored.
Results UNASSIGNED
The median age of the included patients was 67 years (Inter-Quartile Range 60-75 years). Complete response was observed in most patients (
Conclusion UNASSIGNED
Radical chemoradiotherapy is a potential treatment option for patients with superficial esophageal cancer complicated with cirrhosis. However, it can increase the risk of bleeding, which warrants prompt recognition and intervention.

Identifiants

pubmed: 39282115
doi: 10.7717/peerj.18065
pii: 18065
pmc: PMC11401512
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e18065

Informations de copyright

© 2024 Bao et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Hejing Bao (H)

Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cancer Institute of Panyu, Guangzhou, China.

Hehong Bao (H)

Department of Psychosomatic Medicine, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China.

Liping Lin (L)

Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cancer Institute of Panyu, Guangzhou, China.

Yuhuan Wang (Y)

Department of Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.

Longbin Zhang (L)

Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China.

Li Zhang (L)

Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China.

Han Zhang (H)

Department of Oncology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China.

Lingxiang Liu (L)

Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cancer Institute of Panyu, Guangzhou, China.

Xiaolong Cao (X)

Department of Oncology, The Affiliated Panyu Center Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cancer Institute of Panyu, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH